Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia

2020 ◽  
Vol 35 (6) ◽  
pp. 1239-1244 ◽  
Author(s):  
Hassan Galadari ◽  
Swathi Shivakumar ◽  
Torello Lotti ◽  
Uwe Wollina ◽  
Andy Goren ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Narrative Review ◽  
Androgenetic Alopecia ◽  
Low Level Laser Therapy ◽  
Treatment Modalities ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Low-level laser therapy as a treatment for androgenetic alopecia

2016 ◽  
Vol 49 (1) ◽  
pp. 27-39 ◽  
Author(s):  
Ladan Afifi ◽  
Eric L. Maranda ◽  
Mina Zarei ◽  
Gina M. Delcanto ◽  
Leyre Falto-Aizpurua ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Androgenetic Alopecia ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

scholarly journals Low-level laser therapy in temporomandibular joint disorders: a systematic review

2021 ◽  
Vol 14 (2) ◽  
pp. 148-164
Author(s):  
Syed Ansar Ahmad ◽  
◽  
Shamimul Hasan ◽  
Shazina Saeed ◽  
Ateeba Khan ◽  
...  
Keyword(s):  
Systematic Review ◽  
Temporomandibular Joint ◽  
Laser Therapy ◽  
Temporomandibular Joint Disorders ◽  
Low Level Laser Therapy ◽  
Therapeutic Modality ◽  
Treatment Modalities ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Temporomandibular joint disorders (TMDs) encompass a wide array of ailments affecting the temporomandibular joint (TMJ), muscles of mastication, and the allied structural framework. Myofascial pain, internal derangement of the joint, and degenerative joint diseases constitute the majority of TMDs. TMDs usually have a multifactorial etiology, and treatment modalities range from conservative therapies to surgical interventions. Low-level laser therapy (LLLT) has evolved as an efficient non-invasive therapeutic modality in TMDs. Previously conducted systematic reviews and meta-analyses have shown variable results regarding the efficiency of LLLT in TMJ disorder patients. Hence, this systematic review was carried out as an attempt to evaluate the efficacy of LLLT in the treatment of temporomandibular joint disorder patients.

Effect of low-level laser therapy on neurorehabilitation: A narrative review

2022 ◽  
Vol 34 (1) ◽  
pp. 011201
Author(s):  
Milad Soluki ◽  
Arash Abdolmaleki ◽  
Fariba Mahmoudi ◽  
Asadollah Asadi ◽  
Maryam Moazedi
Keyword(s):  
Laser Therapy ◽  
Narrative Review ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

scholarly journals Pemphigus vulgaris and laser therapy: Crucial role of dentists

2014 ◽  
Vol 67 (1-2) ◽  
pp. 38-42 ◽  
Author(s):  
Verica Pavlic ◽  
Vesna Vujic-Aleksic ◽  
Nina Zubovic ◽  
Valentina Veselinovic
Keyword(s):  
Laser Therapy ◽  
Crucial Role ◽  
Pemphigus Vulgaris ◽  
Low Level Laser Therapy ◽  
Treatment Modalities ◽  
Adjunctive Treatment ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Introduction. Pemphigus vulgaris is a relatively rare, chronic, autoimmune vesiculobullous disorder characterized by formation of intraepithelial vesiculae and/or bullae in the skin and mucous membrane. Systemic steroids are considered to be the standard first-line therapy for pemphigus vulgaris. However, for patients unresponsive to standard therapy, the new treatment modalities are being sought. Low-level laser therapy has been accepted as an alternative or adjunctive treatment modality for many conditions in medicine and dentistry. Therefore, this study was aimed at presenting the effects of low-level laser therapy in the treatment of pemphigus vulgaris and to emphasize the crucial role of dentists in early recognition and diagnosis of pemphigus vulgaris. Material and Methods. The articles published until May 2013 were obtained from the Medline/PubMed online database, using following search terms and key words: ?laser therapy? and ?pemphigus vulgaris?, ?low-level laser irradiation? and ?pemphigus vulgaris?, ?lasers? and ?pemphigus vulgaris? and ?pemphigus vulgaris?. Results. Low-level laser therapy could result in immediate and significant analgesia and improved wound healing within the observation period and follow-up. Furthermore, a decrease in patients? discomfort as well as the absence of recurrence of the pemphigus vulgaris lesions has been claimed. Conclusion. Even though available literature suggests that low-level laser therapy can be efficiently used in treatment of oral pemphigus vulgaris, either independently or as a part of combined therapy approach, these results should be interpreted with caution since there are no solid evidence-based proofs to provide the guidelines for the treatment of pemphigus vulgaris with low-level laser therapy. Therefore, further long-term randomized controlled clinical studies are necessary in order to give any solid recommendations on the use of low-level laser therapy in the treatment of pemphigus vulgaris.

Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia

2018 ◽  
Vol 30 (5) ◽  
pp. 489-491 ◽  
Author(s):  
Sophie Wang ◽  
Divya Seth ◽  
Harib Ezaldein ◽  
Raghav Tripathi ◽  
Miesha Merati ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Androgenetic Alopecia ◽  
Low Level Laser Therapy ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

scholarly journals Effects of Buprenorphine, Chlorhexidine, and Low-level Laser Therapy on Wound Healing in Mice

2021 ◽  
Author(s):  
Donna R Webb ◽  
Sheba R Churchill ◽  
Georgette D Hill ◽  
Christopher A McGee ◽  
Min Shi ◽  
...  
Keyword(s):  
Wound Healing ◽  
Laser Therapy ◽  
Punch Biopsy ◽  
Low Level Laser Therapy ◽  
Treatment Modalities ◽  
Wound Area ◽  
Treatment Groups ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

Systemic buprenorphine and topical antiseptics such as chlorhexidine are frequently used in research animals to aid inpain control and to reduce infection, respectively. These therapeutics are controversial, especially when used in wound healing studies, due to conflicting data suggesting that they delay wound healing. Low-level laser therapy (LLLT) has been used to aid in wound healing without exerting the systemic effects of therapies such as buprenorphine. We conducted 2 studies to investigate the effects of these common treatment modalities on the rate of wound healing in mice. The first study used models of punch biopsy and dermal abrasion to assess whether buprenorphine HCl or 0.12% chlorhexidine delayed woundhealing. The second study investigated the effects of sustained-released buprenorphine, 0.05% chlorhexidine, and LLLT on excisional wound healing. The rate of wound healing was assessed by obtaining photographs on days 0, 2, 4, 7, and 9 for the punch biopsy model in study 1, days 0, 1, 2, 4, 6, 8, 11, and 13 for the dermal abrasion model in study 1, and days 0, 3, 6, and 10 for the mice in study 2. Image J software was used to analyze the photographed wounds to determine the wound area.When comparing the wound area on the above days to the original wound area, no significant differences in healing wereobserved for any of the treatment groups at any time period for either study. Given the results of these studies, we believe that systemic buprenorphine, topical chlorhexidine, and LLLT can be used without impairing or delaying wound healing in mice.

Sign in / Sign up

Export Citation Format

Share Document